Peter E. Boyd serves as Executive at Aquestive Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Peter E. Boyd has executed 12 insider transactions totaling $226.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 4, 2025 involved receiving (via award) 20,000 shares valued at $0.
Peter E. Boyd currently holds 288,323 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter E. Boyd has been a net seller of AQST stock. They have purchased $13.5K and sold $212.5K worth of shares.
Peter E. Boyd's most recent insider trade was on Dec 4, 2025, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.00 |
| Discretionary |
| Sep 26, 2025 | AQST | $63.0K | Sale | 10,000 | $6.30 | Discretionary |
| Sep 5, 2025 | AQST | $79.5K | Sale | 15,000 | $5.30 | Discretionary |
| Mar 9, 2024 | AQST | $40.8K | Payment | 8,370 | $4.88 | Discretionary |
| Mar 7, 2024 | AQST | $0 | Award | 86,250 | $N/A | Discretionary |
| Mar 9, 2023 | AQST | $0 | Award | 100,000 | $N/A | Discretionary |
| Jun 14, 2022 | AQST | $4.0K | Purchase | 5,000 | $0.81 | Discretionary |
| Jun 8, 2022 | AQST | $2.2K | Purchase | 2,293 | $0.96 | Discretionary |
| Mar 16, 2020 | AQST | $3.0K | Purchase | 2,000 | $1.50 | Discretionary |
| Aug 12, 2019 | AQST | $2.3K | Purchase | 600 | $3.81 | Discretionary |
| Nov 21, 2018 | AQST | $2.0K | Purchase | 200 | $9.98 | Discretionary |